BPC-157: Research Guide, Mechanism & Protocol Context

Half-Life

~4 hours (injectable), extended oral activity due to gastric stability

Administration

Subcutaneous injection

What is BPC-157?

BPC-157 (Body Protection Compound 157) is a pentadecapeptide derived from a protective protein found in human gastric juice. It is one of the most extensively researched peptides for tissue repair, gut healing, and systemic recovery. Unlike most peptides, BPC-157 is orally active and works through multiple pathways simultaneously.

Mechanism of Action

BPC-157 works primarily by upregulating growth hormone receptors, stimulating nitric oxide synthesis (promoting angiogenesis and blood vessel formation), activating the FAK-paxillin pathway for tendon healing, and modulating the dopaminergic and serotonergic systems. It also activates the VEGF pathway for accelerated tissue vascularization.

BPC-157 Dosing Protocol

250–500 mcg/day subcutaneous or intramuscular injection near injury site. For systemic/gut effects: 500 mcg–1 mg/day oral (capsule or dissolved in water). Cycle: 4–8 weeks. Some researchers use 200 mcg twice daily for chronic conditions.

Administration Routes

Subcutaneous injectionIntramuscular injectionOral (capsule/solution)

Half-Life

~4 hours (injectable), extended oral activity due to gastric stability

Want a personalized protocol? Tell PepBot your goals, health status, and experience level for a custom BPC-157 protocol.

BPC-157 Benefits

Accelerated tendon and ligament healing

Gut lining repair (IBD, leaky gut, ulcers)

Muscle tear recovery

Neuroprotection and nerve regeneration

Anti-inflammatory effects

Bone healing acceleration

Liver protection

Blood pressure modulation

Side Effect Profile

Extremely well-tolerated. Rare reports of mild nausea, dizziness, or injection site discomfort. No significant adverse effects in any published human or animal study.

BPC-157 Stacking Guide

BPC-157 works synergistically with these compounds. Click any to learn more, or ask PepBot to build you a complete stack.

Research & Citations

Stable gastric pentadecapeptide BPC 157: novel therapy in gastrointestinal tract

Current Pharmaceutical Design · 2018

BPC 157 and standard angiogenic growth factors: superior performance of BPC 157

Journal of Physiology-Paris · 2014

Pentadecapeptide BPC 157 enhances the growth hormone receptor expression

Journal of Physiology-Paris · 2010

Frequently Asked Questions about BPC-157

How long does BPC-157 take to work?

Most users report noticeable improvement in injury pain and mobility within 1–2 weeks of daily injections. Gut healing effects can be felt within days. Full tissue repair typically takes 4–8 weeks.

Can I take BPC-157 orally?

Yes — BPC-157 is unique among peptides in that it is stable in gastric acid and orally bioavailable. Oral dosing at 500 mcg–1 mg/day is effective for gut conditions and systemic effects, though injectable is preferred for localized injury healing.

Does BPC-157 cause cancer?

No evidence of carcinogenicity exists in any published study. BPC-157 actually shows anti-tumor properties in some research, and its angiogenic effects are localized to healing tissue, not tumor promotion.

Still have questions about BPC-157?

PepBot has encyclopedic knowledge of BPC-157 — dosing, stacking, interactions, latest research, and personalized protocols. Ask anything.